Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2015 | 09-2014 | 09-2013 | 09-2012 | 09-2011 | |
| Sales | 382 | 175 | 290 | 147 | 296 |
| Gross Profit | 382 | 175 | 290 | 147 | 296 |
| Operating Expenses | 96,356 | 53,451 | 24,880 | 21,236 | 10,126 |
| Operating Income | -95,974 | -53,276 | -24,589 | -21,089 | -9,830 |
| Other Income | 4,036 | -5,444 | -7,114 | -1,021 | 1,045 |
| Pre-tax Income | -91,939 | -58,720 | -31,703 | -22,111 | -8,785 |
| Income Tax | -2 | -5 | N/A | 0 | 0 |
| Net Income Continuous | -91,936 | -58,715 | -31,703 | -22,111 | -8,785 |
| Net Income Discontinuous | N/A | N/A | 0 | 0 | 5,293 |
| Minority Interests | N/A | -95 | -560 | -985 | -364 |
| Net Income | $-91,941 | $-58,630 | $-31,143 | $-21,126 | $-3,129 |
| EPS Basic Total Ops | -1.60 | -1.25 | -1.30 | -1.90 | -0.44 |
| EPS Basic Continuous Ops | -1.60 | -1.25 | -1.32 | -1.90 | -1.18 |
| EPS Basic Discontinuous Ops | N/A | N/A | 0.00 | 0.00 | 0.74 |
| EPS Diluted Total Ops | -1.60 | -1.25 | -1.30 | -1.90 | -0.44 |
| EPS Diluted Continuous Ops | -1.60 | -1.25 | -1.32 | -1.90 | -1.18 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 0.00 | 0.00 | 0.74 |
| EBITDA(a) | $-92,527 | $-51,137 | $-22,710 | $-19,331 | $-9,570 |